Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks ...

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...

French pharma major Sanofi’s saw its shares edge up 1% by early afternoon, despite announcing a disappointment for a vaccine ...

Leafy greens have had a checkered past in terms of food safety — it’s been suspected that pre-harvest irrigation water may ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...

Sanofi and J&J halted a phase 3 E. coli vaccine trial due to insufficient efficacy. Sanofi's Q4 2024 IFRS EPS dropped by ...

An attorney for Harris County, Texas, recently filed a lawsuit against a local utility after learning that E. coli was detected in the city waterways at 1,000 times the legal limit. Newsweek reached ...

Rand Water also emphasised that the distributed water remains safe for human consumption as it is drawn directly from the ...

The Centre for Health Protection is looking into a suspected Shiga toxin-producing Escherichia coli infection cluster ...

A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by an independent data monitoring committee (IDMC) determined that Sanofi and Johnson & Johnson’s ...

State environmental regulators have proposed fining the city of Atlanta nearly $300,000 for wastewater violations at the RM Clayton treatment plant.